Scarborough Advisors LLC acquired a new position in Eli Lilly and Company (NYSE:LLY – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 493 shares of the company’s stock, valued at approximately $279,000. Other institutional investors have also added to or reduced their […]
Chartwell Investment Partners LLC boosted its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 8.9% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 32,530 shares of the company’s stock after buying an additional 2,649 shares during the period. Eli Lilly and […]
Zions Bancorporation N.A. increased its holdings in Eli Lilly and Company (NYSE:LLY – Free Report) by 7.6% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,876 shares of the company’s stock after buying an additional 630 shares during the period. Zions Bancorporation […]
J. L. Bainbridge & Co. Inc. lessened its holdings in Eli Lilly and Company (NYSE:LLY – Free Report) by 5.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 517 shares of the company’s stock after selling 29 shares during […]
Metis Global Partners LLC lifted its stake in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 15.7% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 40,885 shares of the company’s stock after buying an additional 5,544 shares during […]